Successful atopic dermatitis studies depend on more than a strong protocol. Teams must activate the right sites, maintain enrollment momentum, and manage operational complexity across participating countries.
In this case study, see how a biopharmaceutical sponsor partnered with Premier Research to support a Phase III study across Europe, identify country-level enrollment risks early, and complete recruitment approximately two months ahead of revised recovery projections.
By downloading, you’ll discover how the program:
- Used country- and site-level forecasting to identify enrollment risks early
- Expanded within active countries to reduce added startup complexity, cost, and delay
- Enrolled more than 180 patients while maintaining strong operational oversight
The team combined targeted site expansion with practical site engagement and re-engagement strategies to restore recruitment momentum without opening entirely new countries.
Get the full story
By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Premier Research that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.